Phenominer Database Results (16 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
SS/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.3 mmol/l 1.3 3.18 flame atomic emission spectrometry 0.0 0 102253 2682
SR/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.3 mmol/l 1.8 4.41 flame atomic emission spectrometry 0.0 0 102234 2682
SS/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.6 mmol/l 2.4 5.88 flame atomic emission spectrometry 0.0 0 102241 2682
SS/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 138.9 mmol/l 1.2 2.94 flame atomic emission spectrometry 0.0 0 102255 2682
SS/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.2 mmol/l 2.1 5.14 flame atomic emission spectrometry 0.0 0 102242 2682
SR/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 139.6 mmol/l 1.4 3.43 flame atomic emission spectrometry 0.0 0 102250 2682
SR/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.4 mmol/l 1.4 3.43 flame atomic emission spectrometry 0.0 0 102236 2682
SR/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 139.3 mmol/l 1.6 3.92 flame atomic emission spectrometry 0.0 0 102235 2682
SR/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.8 mmol/l 1.6 3.92 flame atomic emission spectrometry 0.0 0 102249 2682
SR/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 139.8 mmol/l 0.7 1.71 flame atomic emission spectrometry 0.0 0 102251 2682
SS/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 141.1 mmol/l 1.8 4.41 flame atomic emission spectrometry 0.0 0 102254 2682
SS/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.4 mmol/l 1.1 2.69 flame atomic emission spectrometry 0.0 0 102256 2682
SR/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.7 mmol/l 0.9 2.2 flame atomic emission spectrometry 0.0 0 102252 2682
SS/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 139.6 mmol/l 1.9 4.65 flame atomic emission spectrometry 0.0 0 102243 2682
SR/Hsd plasma sodium level controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 139.6 mmol/l 2.1 5.14 flame atomic emission spectrometry 0.0 0 102233 2682
SS/Hsd plasma sodium level controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood sodium amount male 91 days-119 days 6 140.7 mmol/l 2.2 5.39 flame atomic emission spectrometry 0.0 0 102244 2682